These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. High prevalence of immunoglobulin A antibody against Epstein-Barr virus capsid antigen in adult patients with lupus with disease flare: case control studies. Chen CJ; Lin KH; Lin SC; Tsai WC; Yen JH; Chang SJ; Lu SN; Liu HW J Rheumatol; 2005 Jan; 32(1):44-7. PubMed ID: 15630723 [TBL] [Abstract][Full Text] [Related]
10. Association of Epstein-Barr virus serological reactivation with transitioning to systemic lupus erythematosus in at-risk individuals. Jog NR; Young KA; Munroe ME; Harmon MT; Guthridge JM; Kelly JA; Kamen DL; Gilkeson GS; Weisman MH; Karp DR; Gaffney PM; Harley JB; Wallace DJ; Norris JM; James JA Ann Rheum Dis; 2019 Sep; 78(9):1235-1241. PubMed ID: 31217170 [TBL] [Abstract][Full Text] [Related]
11. Increased antibody levels to stage-specific Epstein-Barr virus antigens in systemic autoimmune diseases reveal a common pathology. Sternbæk L; Draborg AH; Østerlund MT; Iversen LV; Troelsen L; Theander E; Nielsen CT; Jacobsen S; Houen G Scand J Clin Lab Invest; 2019; 79(1-2):7-16. PubMed ID: 30727744 [TBL] [Abstract][Full Text] [Related]
12. Correlation between cytomegalovirus infection and Raynaud's phenomenon in lupus nephritis. Stratta P; Canavese C; Ciccone G; Santi S; Quaglia M; Ghisetti V; Marchiaro G; Barbui A; Fop F; Cavallo R; Piccoli G Nephron; 1999 Jun; 82(2):145-54. PubMed ID: 10364707 [TBL] [Abstract][Full Text] [Related]
13. Epstein-Barr virus antibodies and risk of multiple sclerosis: a prospective study. Ascherio A; Munger KL; Lennette ET; Spiegelman D; Hernán MA; Olek MJ; Hankinson SE; Hunter DJ JAMA; 2001 Dec; 286(24):3083-8. PubMed ID: 11754673 [TBL] [Abstract][Full Text] [Related]
14. Exposure to Epstein-Barr virus infection is associated with mild systemic lupus erythematosus disease. Zandman-Goddard G; Berkun Y; Barzilai O; Boaz M; Blank M; Ram M; Sherer Y; Anaya JM; Shoenfeld Y Ann N Y Acad Sci; 2009 Sep; 1173():658-63. PubMed ID: 19758212 [TBL] [Abstract][Full Text] [Related]
15. Anti-Epstein-Barr virus antibodies in Beijing during 2013-2017: What we have found in the different patients. Cui J; Yan W; Xu S; Wang Q; Zhang W; Liu W; Ni A PLoS One; 2018; 13(3):e0193171. PubMed ID: 29494658 [TBL] [Abstract][Full Text] [Related]
16. Association of Epstein-Barr virus infection with systemic lupus erythematosus in Taiwan. Lu JJ; Chen DY; Hsieh CW; Lan JL; Lin FJ; Lin SH Lupus; 2007; 16(3):168-75. PubMed ID: 17432101 [TBL] [Abstract][Full Text] [Related]
17. Real-Time PCR of cytomegalovirus and Epstein-Barr virus in adult Egyptian patients with systemic lupus erythematosus. Mohamed AE; Hasen AM; Mohammed GF; Elmaraghy NN Int J Rheum Dis; 2015 May; 18(4):452-8. PubMed ID: 24341363 [TBL] [Abstract][Full Text] [Related]
18. Elevated immunoglobulin G antibodies to the proline-rich amino-terminal region of Epstein-Barr virus nuclear antigen-2 in sera from patients with systemic connective tissue diseases and from a subgroup of Sjögren's syndrome patients with pulmonary involvements. Yamazaki M; Kitamura R; Kusano S; Eda H; Sato S; Okawa-Takatsuji M; Aotsuka S; Yanagi K Clin Exp Immunol; 2005 Mar; 139(3):558-68. PubMed ID: 15730403 [TBL] [Abstract][Full Text] [Related]
19. Lack of evidence of active lytic replication of Epstein-Barr and cytomegaloviruses in patients with systemic lupus erythematosus. Lau CS; Yuen KY; Chan KH; Wong RW Chin Med J (Engl); 1998 Jul; 111(7):660-5. PubMed ID: 11245059 [TBL] [Abstract][Full Text] [Related]
20. Detection of antibodies to the Epstein-Barr virus nuclear antigens in the sera from patients with systemic lupus erythematosus. Kitagawa H; Iho S; Yokochi T; Hoshino T Immunol Lett; 1988 Mar; 17(3):249-52. PubMed ID: 2836302 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]